Drug-coated stents

References

• Hoffmann R, Mintz GS. Coronary in-stent restenosis — predictors, treatment and prevention. Eur Heart J 2000; 21: 1739–49.
   PubMed Web of Science ®Google Scholar
• Serruys PW, de Jaegere P, Kiemeneij F et al. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331: 489–95.
   PubMed Web of Science ®Google Scholar
• Fischman DL, Leon MB, Baim DS et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994; 331: 496–501.
   PubMed Web of Science ®Google Scholar
• Al Suwaidi J, Berger PB, Holmes DR. Coronary artery stents. J Am Med Assoc 2000; 284: 1828–36.
   Web of Science ®Google Scholar
• Kasaoka S, Tobis JM, Akiyama T et al. Angiographic and intravascular ultrasound predictors of in-stent restenosis. J Am Coll Cardiol 1998; 32: 1630–5.
   PubMed Web of Science ®Google Scholar
• Suselbeck T, Latsch A, Siri H et al. Role of vessel size as a predictor for the occurrence of in-stent restenosis in patients with diabetes mellitus. Am J Cardiol 2001; 88: 243–7.
   PubMedGoogle Scholar
• Leon MB, Teirstein PS, Moses JW et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001; 344: 250–6.
   PubMed Web of Science ®Google Scholar
• Waksman R, Bhargava B, White L et al. Intracoronary beta-radiation therapy inhibits reccurence of in-stent restenosis. Circulation 2000; 102: 951–8.
   PubMedGoogle Scholar
• Teirstein PS, Massulo V, Jani S et al. Three-year clinical and angiographic follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 2000; 101: 360–5.
   PubMed Web of Science ®Google Scholar
• Waksman R, Ajani AE, White RL et al. Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma-radiation in patients with in- stent restenosis: Washington Radiation for In-Stent Restenosis Trial plus 6 months of clopidogrel (WRIST PLUS). Circulation 2001; 103: 2332–5.
   PubMed Web of Science ®Google Scholar
• Bertrand OE, Lehnert S, Mongrain R et al. Early and late effects of radiation treatment for prevention of coronary restenosis: a critical appraisal. Heart 1999; 82: 658–62.
   PubMedGoogle Scholar
• Kuntz RE, Moses JW, Abizaid AAC, Bourassa MG. Intravascular sonotherapy in human coronary arteries: first results of a feasability trial. J Am Coll Cardiol 2001; 37 (Suppl): 37–45A.
   Google Scholar
• Rockson SG, Lorenz DP, Cheong WE, Woodburn KW. Photoangioplasty: an emerging clinical cardiovascular role for photodynamic therapy. Circulation 2000; 102: 591–6.
   PubMedGoogle Scholar
• Côté G, Tardif JC, Lespérance J et al. Effects of probucol on vascular remodeling after coronary angio- plasty. Multivitamins and Protocol Study Group. Circulation 1999; 99: 30–5.
   PubMed Web of Science ®Google Scholar
• Tsuchikane E, Fukuhara A, Kobayashi T et al. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty. Circulation 1999; 99: 21–6.
   Google Scholar
• Lincoff AM, Furst JG, Ellis SG et al. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. J Am Coll Cardiol 1997; 29: 808–16.
   PubMed Web of Science ®Google Scholar
• Alt E, Haehnel I, Beilharz C et al. Inhibition of neointima formation after experimental coronary artery stenting — a new biodegradable stent coating releasing hirudin and the prostacyclin analogue iloprost. Circulation 2000; 101: 1453–8.
   PubMedGoogle Scholar
• Heldman AW, Cheng L, Jenkins M et al. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation 2001; 103: 2289–95.
   PubMed Web of Science ®Google Scholar
• Whelan DM, van der Giessen WJ, Krabbendam SC et al. Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries. Heart 2000; 83: 338–45.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Kopia G, Hayashi S et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001; 104: 1188–93.
   PubMed Web of Science ®Google Scholar
• Farb A, Heller PF, Shroff S et al. Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 2001; 104: 473–9.
   PubMed Web of Science ®Google Scholar
• Fontaine AB, Borsa JJ, Dos Passos S et al. Evaluation of local abciximab delivery from the surface of a polymer-coated covered stent: in vivo canine studies. J Vasc Intervent Radiol 2001; 12: 487–92.
   PubMedGoogle Scholar
• Ahn YK, Jeong MH, Kim JW et al. Preventive effects of the heparin-coated stent on restenosis in the porcine model. Cathet Cardiovasc Intervent 1999; 48: 324–30.
   PubMed Web of Science ®Google Scholar
• Herrmann R, Schmidmaier G, Märkl B et al. Anti- thrombogenic coating of stents using a biodegradable drug delivery technology. Thromb Haemost 1999; 82: 51–7.
   PubMedGoogle Scholar
• Hong MK, Kornowski R, Bramwell O et al. Paclitaxel- coated Gianturco-Roubin II (GRII) stents reduce neo- intimal hyperplasia in a porcine coronary in-stent restenosis model. Coron Artery Dis 2001; 12: 513–5.
   PubMedGoogle Scholar
• Al-Lamee K. Surface modification of stents for improving biocompatibility. Med Device Technol 1999; 1: 12–20.
   Google Scholar
• Nakayama Y, Ji-Youn K, Nishi S et al. Development of high-performa nce stent: gelatinous photogel-coated stent that permits drug delivery and gene transfer. J Biomed Mater Res 2001; 57: 559–66.
   PubMed Web of Science ®Google Scholar
• Sousa JE, Costa MA, Abizaid AC et al. Sustained suppression of neointimal proliferation by sirolimus- eluting stents — one year angiographic and intra- vascular ultrasound follow-up. Circulation 2001; 104: 2007–11.
   PubMed Web of Science ®Google Scholar
• Teirstein PS. Living the dream of no restenosis. Circulation 2001; 104: 1996–8.
   PubMedGoogle Scholar
• Honda Y, Grube E, de la Fuente LM et al. Novel drug- delivery stent — intravascular ultrasound observations from the first human experience with the QP2–eluting polymer stent system. Circulation 2001; 104: 380–3.
   PubMedGoogle Scholar
• De la Fuente LM, Miano J, Mrad J et al. Initial results of the Quanam drug-eluting stent (QuaDS-QP-2) registry (BARDDS) in human subjects. Cathet Cardiovasc Intervent 2001; 53: 480–8.
   PubMedGoogle Scholar
• Drachman DE, Edelman RE, Seifert P et al. Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. J Am Coll Cardiol 2000; 36: 2325–32.
   PubMed Web of Science ®Google Scholar
• Regar E, Sianos G, Serruys PW. Stent development and local drug delivery. Br Med Bull 2001; 59: 227–8.
   PubMed Web of Science ®Google Scholar
• El-Ommar MM, Dangas G, Iakovou I et al. Update on in- stent restenosis. Curr Intervent Cardiol Rep 2001; 3: 296–305.
   PubMedGoogle Scholar
• Lowe HC, Khachigian LM. Coating stents with antirestenotic drugs: the blunderbuss or the magic bullet? Circulation 2002; 105: e29.
   Google Scholar
• Gunn J, Cumberland D. Stent coatings and local drug delivery. Eur Heart J 1999; 20: 1693–1700.
   PubMed Web of Science ®Google Scholar
• Edelman ER, Ettenson DS. Local drug delivery: an emerging approach in the treatment of restenosis. Vasc Med 2000; 5: 97–102.
   PubMedGoogle Scholar
• Serruys PW, van Hout B, Bonnier H et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 1998; 352: 673–81.
   PubMed Web of Science ®Google Scholar
• Karrillon GJ, Morice MC, Benveniste E et al. Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy. 30–day clinical outcome of the French Multicenter Registry. Circulation 1996; 94: 1519–27.
   PubMed Web of Science ®Google Scholar
• Taniuchi M, Kurz HI, Lasala JM. Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population. Circulation 2001; 104: 539–43
   PubMed Web of Science ®Google Scholar
• Van der Giessen WJ, Regar E, Harteveld MS et al. ‘Edge effect’ of 32P radioactive stents is caused by the combination of chronic stent injury and radioactive dose falloff. Circulation 2001; 104: 2236–41.
   PubMed Web of Science ®Google Scholar
• Seabra-Gomes R. Radioactive stents to reduce reste- nosis: time for an epitaph? Eur Heart J 2001; 22: 621–3.
   PubMedGoogle Scholar
• Kutryk MJ, van Dortmont LM, de Crom RP et al. Seeding of intravascular stents by the xenotrans- plantation of genetically modified endothelial cells. Semin Interv Cardiol 1998; 3: 217–20.
   PubMedGoogle Scholar
• Ye YW, Landau C, Willard JE et al. Bioresorbable microporous stents deliver recombinant adenovirus gene transfer vectors to the arterial wall. Ann Biomed Eng 1998; 26: 398–408.
   PubMed Web of Science ®Google Scholar
• Tamai H, Igaki K, Kyo E et al. Initial and 6-months results of biodegradable poly-L-lactic acid coronary stents in humans. Circulation 2000; 102: 399–404.
   PubMed Web of Science ®Google Scholar
• Tsuji T, Tamai H, Igaki K et al. One year follow-up of biodegradable self-expanding stent implantation in humans [Abstract]. J Am Coll Cardiol 2001; 37: 1A.
   PubMedGoogle Scholar
• Liistro F, Colombo A. Late acute thrombosis after paclitaxel eluting stent implantation. Heart 2001; 86: 262–4.
   PubMed Web of Science ®Google Scholar
• Gallo R, Padurean A, Jayaraman T et al. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation 1999; 99: 2164–70.
   PubMed Web of Science ®Google Scholar
• Morice M, Serruys PW, Sousa J et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346(23): 1773–80.
   PubMed Web of Science ®Google Scholar
• Bauters C, Banos JL, Van Belle E et al. Six-month angiographic outcome after successful repeat percutaneous interventions for in-stent restenosis. Circulation 1998; 97: 318–21.
   PubMed Web of Science ®Google Scholar
• Mehran R, Dangas G, Abizaid AS et al. Angiographic pattern of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999; 100: 1872–8.
   PubMed Web of Science ®Google Scholar
• Baim DS, Cutlip DE, Sharma SK et al. Final results of the Balloon vs. Optimal Atherectomy Trial (BOAT). Circulation 1998; 97: 309–11.
   PubMedGoogle Scholar
• Vom Dahl J, Dietz U, Haager PK et al. Rotational atherectomy does not reduce recurrent in-stent restenosis: results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST). Circulation 2002; 105: 583–8.
   PubMed Web of Science ®Google Scholar